chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Sore arm at injection site; Initial information received on 23-Nov-2020 regarding an unsolicited valid non-serious case received from a patient via social media.  This case involves patient (unknown demographics) who had Sore arm at injection site (Injection site pain) while he/she received vaccine INFLUENZA VACCINE.  The patient's medical history, past medical treatment, vaccination, concomitant medication and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer lot number not reported via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patients who had Sore arm at injection site (Injection site pain) unknown latency following the administration of INFLUENZA VACCINE.  Laboratory details were not reported.  It was not reported if the patient received a corrective treatment.  The event outcome was unknown.
Breast pain on same side as the shot; Low grade fever; This spontaneous case was reported by a consumer and describes the occurrence of BREAST PAIN (Breast pain on same side as the shot) and PYREXIA (Low grade fever) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032B21A and 032B21A) for COVID-19 vaccination.     Concurrent medical conditions included Asthma. Concomitant products included METFORMIN and BUDESONIDE, FORMOTEROL FUMARATE (SYMBICORT) for an unknown indication.   On 01-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Jul-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-Jul-2021, the patient experienced BREAST PAIN (Breast pain on same side as the shot) and PYREXIA (Low grade fever). At the time of the report, BREAST PAIN (Breast pain on same side as the shot) had not resolved and PYREXIA (Low grade fever) outcome was unknown.            No treatment medication was provided. The patient was waiting to get an appointment with the physician and would follow back when possible.   This case was linked to MOD-2021-246443 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 24-Aug-2021: follow up : Breast pain event outcome was updated to not recovered
Fever 103.8 (2 days)  Rash on neck, trunk, upper thighs
Provider noticed localized reaction/rash on leg where KINRIX was given. Rash did not last long. BENADRYL was given as a treatment and rash was disappearing before BENADRYL was given. No rash was present upon discharge.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. Patient's concurrent conditions, medical history and concomitant medications were not reported. On unspecified dates, the patient was vaccinated with a series of doses of RECOMBIVAX HB injection (doses, routes of administration, lot # and expiry dates were not reported). After completion of the series, the patient failed to produce titers. Therefore, on unspecified dates, the patient received a second full series of doses of RECOMBIVAX HB injection (doses, routes of administration, lot # and expiry dates were not reported). After the second series of RECOMBIVAX HB was completed, the patient still did not produce any titers. The outcome of the events and causal relationship between RECOMBIVAX HB and the events were not reported. Additional information has been requested.
Hospitalization: 12/26/2022 - 1/9/2023 (14 days) Presentation to the ED: shortness of breath.  COVID + date: 12/26/22 Treatment: remdesivir.  Discharge to: Hospice/Home.   013M20A 3/3/2021 046A21A 3/31/2021 026D21A 10/22/2021 059A22A  6/13/2022
Pt c/o dull headache 2/10 and flushed feeling 25 mins after receiving 1st dose of the vaccine. He reported that his only med hx is allergy to PCN. He was assessed and monitored by NP, EMT and paramedic. BP - 135/94, 134/95, resp - 12, HR- 74, O2 sat - 97%
Joint/muscle pain to extremity of injection site. Swelling,  redness, heat to upper arm between shoulder and elbow.
Information has been received from a nurse concerning a 23 year old female with an allergic reaction to dapsone and a history of vulval lesion who on 19-JUN-2007 was vaccinated with a first dose of Gardasil (lot# 656050/0245U) 0.5mL IM.  Concomitant therapy included dermatologic (unspecified) therapy for acne.  On 20-AUG-2007 the patient was vaccinated with a second dose of Gardasil (lot# unknown) 0.5mL IM.  On 21-AUG-2007 the patient developed an itchy rash on both arms an abdomen.  Medical attention was sought.  The patient's itchy rash on both arms and abdomen persisted.  No other information was available at this time.  Additional information has been requested.
herpes zoster; This initial spontaneous report was received on from a lawyer regarding a case in litigation and refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant medication were not provided.   On an unspecified date, the patient was vaccinated with a dose zoster vaccine live (ZOSTAVAX) (dosage regimen was not reported) for the long-term prevention of shingles.  On an unspecified date, the patient presented shingles. As a direct and proximate result, the patient symptoms had resulted in physical limitations not presented prior vaccination. The patient also experienced mental and emotional distress due to resulting physical limitations and seriousness of patient's conditions.  As a direct and proximate result, the patient suffered severe and permanent physical injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury.   The reporter considered the event of shingles to be related to zoster vaccine live (ZOSTAVAX).
Pt received varicella vaccine and came down with very mild disease- #90 Pox, no complications.
196 patients received 0.25mL of Moderna COVID-19 Vaccine, Bivalent; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of UNDERDOSE (196 patients received 0.25mL of Moderna COVID-19 Vaccine, Bivalent) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On an unknown date, the patient experienced UNDERDOSE (196 patients received 0.25mL of Moderna COVID-19 Vaccine, Bivalent) and NO ADVERSE EVENT (No adverse event). At the time of the report, UNDERDOSE (196 patients received 0.25mL of Moderna COVID-19 Vaccine, Bivalent) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for UNDERDOSE (196 patients received 0.25mL of Moderna COVID-19 Vaccine, Bivalent).    No concomitant medication was reported.  It was unknown if the patient had received any other vaccine 4 weeks prior to COVID-19 vaccine.  No treatment information was provided.   This case was linked to US-MODERNATX, INC.-MOD-2022-689916 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 27-Dec-2022: Live follow up information received: Patient age group and narrative updated.; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-689916:
No adverse event related to the vaccination. I have been experiencing symptoms that may be due to lung cancer. I am scheduled for a pulmonary CT scan to determine the cause.
Felt like swelling under the skin starting from the injection site in the left shoulder.  Traveled to my left hand fingertips.  finally felt swelling in the left side of my face.  Subsided within about an hour.
no adverse event; Improperly stored vaccines administered; This spontaneous report was received from other and refers to some patients. The patient's concurrent conditions, medical history and concomitant medications were not reported.   On 28-JUL-2023, the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection, 0.5 milliliter, three dose series, lot #W014513, expiration date: 26-JAN-2025, administered for prophylaxis (strength, and route of administration were not provided).   On 28-JUL-2023, 5 patients in total and additional patients were administered the affected hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) from the lot involved in a temperature excursion at the same location (Product storage error). No adverse events reported (No adverse event).   This is a non-valid case due to no patient's identifiers.   Follow up information has been received from an other health professional on 09-AUG-2023 and refers to a 11-year-old female patient. Concomitant medications included diphtheria vaccine toxoid (+) pertussis vaccine acellular (+) tetanus vaccine toxoid (TDAP) (lot # 213723, expiration date: 17-OCT-2025 via Right Deltoid) and meningococcal vaccine conj (lot # AMVA767A, expiration date: ??-DEC-2023 via Left Deltoid). The patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) via Left Deltoid.    This is one of several reports from same reporter. ; Sender's Comments:  US-009507513-2309USA000747: US-009507513-2309USA000746: US-009507513-2308USA001806: US-009507513-2309USA000744: US-009507513-2309USA000743: US-009507513-2309USA000748:
Presented to ED with 2 weeks of SOB, not feeling well. Had fallen 2 weeks prior to admission and landed on her back. Was hypoxic on admission and required 10 L of supplemental oxygen to maintain saturations > 90%. Was transferred to this facility for further care. SARS-CoV-2 test was positive at OSH (PCR + but antigen test negative) and PCR test + here. CXR suspicious for multifocal PNA consistent with COVID-19. Currently admitted.
5/13/2021 after 20min my throat and eyes got dry and it felt like something was stuck in the back of my throat and could not clear it. Also, mucous kept on coming up just like when I eat shrimp. I knew at that time I was having an anaphylaxis and took an EpiPen to stop it. It cleared up mostly after that and taking Benadryl liquid. About 10 days later(5/23/2021) I had a nasal infection and was on prednisone for 10 days.
I got forst shot on 8/5/21. On 8/23 i syarted to feel like I had a cold. So i cancelled my second shot scheduled for 8/26.  I tested negative for covid on 8/26 and 8/28.  Symptoms continued to get worse and I tested positive on 8/30. Pretty lame that I did not stop my daily activities or traveling all through covid and NEVER got sick... but then due to all the media pressure, I acquiesce and get this stupid vaccine and 2 weeks later develop covid. And now they are saying people.with natural immunity are having better immunity against the delta variant. The exact same situation for my husband.  Exact.  Thanks for nothing.
tested positive for the Covid19 virus; tested positive for the Covid19 virus; This is a spontaneous report from a contactable consumer.  A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. It was stated that on an unspecified date, patient reported they had been vaccinated but tested positive for the Covid19 virus. The patient underwent lab tests and procedures which included sars-cov-2 test: positive on an unspecified date. Event took place after use of product. The outcome of Covid-19 was unknown.  No follow-up attempts are possible, information about lot/batch number cannot be obtained. No further information is expected.
Fever; muscle aches; nausea; vomiting; sore arm; headache; dose received: 3; dose received: 3; This is a spontaneous report from a contactable consumer (patient). A 29-year-old non pregnant female patient received third dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, lot number was not reported, expiration date was not reported), via an unspecified route of administration, administered in left arm on 17Oct2021 (at the age of 29-years-old) as dose 3 (Booster), single for covid-19 immunization at pharmacy or drug store. The patient medical history was not reported.  Concomitant medications included escitalopram, lamotrigine, paracetamol (TYLENOL), all taken for unknown indications from an unknown date. Other medications the patient received in two weeks included escitalopram, lamotrigine, tylenol. The patient historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, lot number was unknown, expiration date was not reported), via an unspecified route of administration, administered in left arm on 17Mar2021 (at the age of 29-years-old) as dose 1, single and received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, lot number was unknown, expiration date was not reported), via an unspecified route of administration, administered in left arm on 07Apr2021 (at the age of 29-years-old) as dose 2, single for covid-19 immunization at pharmacy or drug store. The patient did not receive any other vaccine in four weeks. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. It was reported that on 18Oct2021 the patient experienced fever, muscle aches, nausea, vomiting, sore arm, headache. Tylenol was received as treatment for the adverse events. Therapeutic measures were taken as a result of fever, muscle aches, nausea, vomiting, sore arm, headache. The outcome of the events fever, muscle aches, nausea, vomiting, sore arm, headache was recovering.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
received Shingrix adjuvant portion alone; received Shingrix adjuvant portion alone; This case was reported by a nurse via call center representative and described the occurrence of inappropriate preparation of medication in a adult male patient who received Herpes zoster (Shingrix) (batch number 45G33, expiry date 24th August 2023) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.       Additional Information: GSK Receipt Date: 13th Apr 2022 Reporter's Comments: The patient received Shingrix adjuvant portion alone by error. The reporter did not consent to follow-up. Additional Supportive Information: The patient received Shingrix adjuvant portion alone which led to inappropriate preparation of medication and inappropriate dose of vaccine administered.
FEVER; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, the patient experienced fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of fever was not reported. This report was non-serious.
Severe pain in right eye. Significant enough that she had difficulty opening eye and was immobilized. Both eyes red. Wanted to fall asleep but had difficulty due to pain. After 1.5 hours fell asleep from pain. Woke up 3 hours later still with pain in eye and unable to open eyes. Fell asleep again and slept till morning. Woke with no pain.
She had swollen lips the day after and was treated with Benadryl. She was ok Saturday afternoon. Then on Sunday night @ 1030 pm she got hives all over body.  Taking Claratin and Calamine Lotion as per doctor.
Severe headaches, body aches head to toe, extremely fatigued that I cannot stay awake. I have a slight cough and yesterday I was diagnosed with pneumonia.  I do not believe this is vaccine related, however just in case this is common, I am making a report for it.
Apprx 7 minutes after receiving vaccine, I experienced a sensation in my chest, upper arms, and neck areas. I also experienced a slight metallic taste in my mouth. I also sensed a somewhat increased heart rate and some slight dizziness. I did NOT experience any breathing difficulties but maybe had a very slight wheeze sensation. These reactions lasted only about 8 to 10 minutes then started easing away. I was monitored a full 30 minutes and then released after reporting I felt ok then.
Patient had syncopal like episode with movement of all 4 limbs, lasted less than 10 seconds, afterwards completely normal exam and vitals.
A spontaneous report has been received from a Health Professional concerning a patient of unknown gender, who had been receiving FLUMIST, 0. 1 millilitres, unknown. FLUMIST started during Nov-2015. It was reported that FLUMIST with temperature excursion administered to five patients and FLUMIST temperature excursion maximum 47 fahrenheit degrees for approximately 24h and also stated that FLUMIST 0.1 ml dose given to five patients. The outcome of the event of FLUMIST with temperature excursion administered to five patients FLUMIST excursion maximum 47 Fahrenheit degrees for approximately 24 H and FLUMIST 0.1 ml dose given to 5 patients is unknown. The report was considered to be non-serious.
This is a prospective pregnancy case. This 28-year-old female subject was enrolled in a study. The subject received BOOSTRIX (injection) .5 ml on 3rd February 2015. Concurrent medical conditions included hypertension. The subject's last menstrual period was on 26th May 2014 and estimated date of delivery was 21st March 2015. The subject received BOOSTRIX at week 36 of the pregnancy. On an unknown date, an unknown time after receiving BOOSTRIX the subject developed vaccine exposure during pregnancy (Non-serious). The outcome of vaccine exposure during pregnancy was unknown. The pregnancy was ongoing.
10:00 am - received moderna  10:10 am - Reports itchy eyes and mild facial flushing noted. Given 2 PO Benadryl tablets with water. No SOB, HA or dizziness. No angioedema. BP 135/71 P 78 O2 96. Pregnant wife at BS. 10:20 am - Reports eyes are feeling less itchy. Facial flushing decreased. No other sx reported. BP 124/71 P 75 O2 95.  10:45 am - Reports eyes are no longer itching. States he is feeling effects of benedryl. Normal facial appearance. No other sx reported. BP 96/55 P 80 O2 95  10:46 am - Pt discharged with wife in stable condition and without sx.
COVID-19; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (COVID-19) in an 83-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7144(15) or (B)) for COVID-19 prophylaxis.     Concurrent medical conditions included Hypercholesteraemia (not really, she just started taking meds for that) and Blood pressure high (not really, she just started taking meds for that). Concomitant products included CLOPIDOGREL BISULFATE (PLAVIX) for an unknown indication.    On 06-Sep-2022, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. In 2022, the patient experienced COVID-19 (COVID-19). The patient was treated with NIRMATRELVIR, RITONAVIR (PAXLOVID) for COVID-19, at an unspecified dose and frequency. At the time of the report, COVID-19 (COVID-19) had resolved.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments.   Patient takes Plavix as blood thinner was needed. Patient received first dose on 24-Jan-2021 with lot number  042L20A, second dose on 26-Feb-2021 with lot number 001A21A, third dose on 22-Oct-2021 with lot number 048F21A, 1st booster on 22-Apr-2022 with lot number 065K21A. Patient had COVID over weekend last year. Patient cannot remember the exact dates. Patient stayed at home and took Paxlovid.
Arm soreness, onset of heavy menstrual cramping and bleeding within a few hours, reduction in milk supply breastfeeding with pumping milk session (approx 3-4 ounces less than usual), fatigue, nausea
I am not sure this is what i shoud be filling out - just wanted to report what seemed like pretty bad symptoms on first dose by all info i have found. The actual shot was given by another facility than listed previously. I recieved the first dose of Pfizer at  Health Dept . No other location information was provided by them.  When i got the shot, a blood vein and possibly a nerve was hit. The nurse did everything properly i think to correct and notify other RN. It caused immediate pain in left fingers and arm felt heavy. That continued for days, but not too bad and injection site itself really was not very sore. My concern was how sick I felt starting within 6 hours of the injection and how long it lasted. I had pretty much instant nausea- no vomiting- mild but persistant, severe fatigue and general overall uneasy/sick feeling. Joint pain started within the 6 hours, along with a few odd pains in neck and right abdomen.  Was extremely chilled for hours, pretty bad tension /tight feeling headache, jittery feeling and foggy. I took a 500mg Tylenol about 8 hours after the shot, and it helped to relieve most symptoms to a degree that was nagging, but tolerable. I pretty much went through this for about the next 3 days and off/on to the 5th day
Temp 100-101>started 8/21/13 thru 8/25/13 a long with fussiness, pulling at ears. To Dr on 8/22/13 told was probably due to teething. 8/25/13 fine red rash chest, back. L side of neck and face also puffiness of face and eyes to ER and given oral steroid. Rx for Benadryl. Also had quarter size  red whelp L thigh. Starting evening 8/22 thru 8/29/13.
at midnight same day as 1st maderna shot i started vomiting for the next 18 hour. vomiting stopped on Saturday. By Sunday 11th April I needed to go to the ER for chest and stomach pain. i was there for 8 hours while they tried to control the pain. the doctor noticed that my blood pressure was reading very high yet my heartrate was only 40. the medication they gave me for abdominal pain helped some.  I did notice, from then on,  that almost every time i stood up  I would get very dizzy. 2 days ago, may 1st i was bending over to plant a couple of flowers and got dizzy .every time i eat, my stomach is upset for a short time. I have lost, according to my scales, 20 lbs. that part I don't mind.
When laying down at night I had mild feeling of heart racing and felt as if I were going to pass out instead of falling asleep.  This happened 2 nights in a row and then had a night of no symptoms.  Then the next night had more severe symptoms of the same type, with the addition of entire upper body tingling sensations which prompted me to go to the ER.  Doctors did blood tests, EKG, chest X-ray and pretty much didn?t do anything else but make me wait around for about 11hrs.  No answer to what caused symptoms.